| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/11/2009 | CN101381412A Polymer/recombinant human erythropoietin couple |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381408A Cobratide extraction method, cobratide extracted thereby and formulation containing cobratide |
| 03/11/2009 | CN101381407A Preparation and application of polypeptide medicine for treating mycobacterium tuberculosis infection |
| 03/11/2009 | CN101381406A Sword prawn allergen protein and preparation and application in medicine thereof |
| 03/11/2009 | CN101381405A Genetic engineering tumor targeting KCT-W1 polypeptides and preparation method and application |
| 03/11/2009 | CN101381404A Targeting tumor protein KCT-W2, preparation method and application |
| 03/11/2009 | CN101381403A Alpha type conotoxin peptide derivates and use thereof |
| 03/11/2009 | CN101381401A Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 03/11/2009 | CN101380476A Albumin-binding derivatives of therapeutic peptides |
| 03/11/2009 | CN101380464A Method for treating a movement disorder |
| 03/11/2009 | CN101380463A Composition and its therapeutic use |
| 03/11/2009 | CN101380462A Obtaining method of novel insulin oil-phase solution and preparation technique thereof |
| 03/11/2009 | CN101380461A Efficient thymosin enteric-coated tablets and thymosin for injection |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467601C PIM-3 kinase as a target for type 2 diabetes mellitus |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467598C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467597C Fungal cell wall synthesis gene |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467490C Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/11/2009 | CN100467487C Multifunctional polypeptide |
| 03/11/2009 | CN100467482C New antitumoral compounds |
| 03/11/2009 | CN100467481C Antibacterial polypeptide from Amolops loloensis and its pharmaceutical use |
| 03/11/2009 | CN100467476C Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/11/2009 | CN100467061C Preparation method of scorpionfish-ink polysaccharide |
| 03/11/2009 | CN100467060C Intratumorally administered lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467059C Use of lactoferrin in the treatment of malignant neoplasms diseases |
| 03/11/2009 | CN100467058C Pharmaceutical and cosmetic compositions comprising PLGF-1 |
| 03/11/2009 | CN100467057C Nerve growth factor external application medicine and its preparing method |
| 03/10/2009 | US7501506 Pentopyranosyl nucleic acid does not non-covalently bond or hybridize to naturally occurring DNA or RNA; conjugated through a covalent linkage to the biotin molecule; diagnosis, gene therapy |
| 03/10/2009 | US7501503 Compositions and methods for inhibiting RNase H activity of retroid reverse transcriptase |
| 03/10/2009 | US7501499 Modified hemoglobin and methods of making same |
| 03/10/2009 | US7501497 Comprising transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptor moiety and an immunoglobulin moiety comprising a heavy chain constant region of an immunoglobulin; interfere with binding of a tumor necrosis factor receptor with its ligand; antitumor agents |
| 03/10/2009 | US7501493 Dried blood factor composition comprising trehalose |
| 03/10/2009 | US7501486 Pentapeptide having the amino acid sequence CRPPR (cysteine-arginine-proline-proline-arginine); peptides and peptidomimetics; cardiovascular disorders; drug and gene delivery |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501484 Methods and DNA constructs for high yield production of polypeptides |
| 03/10/2009 | US7501455 For parental injection of water insoluble drugs such as paclitaxel, propofol, amphotericin B, camptothecin, gemfibrozil and cyclosporin A; plasma protein such as serum albumin, an immunoglobulin, a glycoprotein, an interferon, or an interleukin, in controlled aggregation state |
| 03/10/2009 | US7501402 Acidic oligosaccharide fragments produced by marine sponges and sea urchin embryos; potent stimulators of natural killer cells and gamma delta T cells; cancer, viral infections |
| 03/10/2009 | US7501401 Administering oligonucleotide containing optimal nucleotide binding site for the transcription factor for therapy of disease associated with hyper-activated signal transduction pathways, particularly malignancy |
| 03/10/2009 | US7501400 Inhibition of gastric acid production and/or secretion |
| 03/10/2009 | US7501398 Peptide; HIV-1 PR inhibitors which effectively interferes with the folding mechanism of the protein itself, thus destabilizing it and making it prone to proteolysis; acquired immune deficiency syndrome |
| 03/10/2009 | US7501397 Helical peptidomimetics with enhanced activity |
| 03/10/2009 | US7501394 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 03/10/2009 | US7501393 Dry eye disease; conditions or diseases which are related to immune response, inflammatory response, or parasitic or other infection; parenteral administration |
| 03/10/2009 | US7501392 Method of treatment of viral hepatitis C with interferon alpha 5 |
| 03/10/2009 | US7501391 Modulation of graft versus host disease by providing the organs with gene regulatory peptides, which control translocation and/or transcription factors; immunology |
| 03/10/2009 | US7501265 Method for producing and cleaving a fusion proteins with an n-terminal chymosin pro-peptide |
| 03/10/2009 | US7501263 Nucleic acids encoding mammalian T-type calcium channels |
| 03/10/2009 | US7501261 Contacting target cellular nucleic acid in test cell with reagent that detects tumor suppressor lung cancer 1 (TSLC1) and detecting a reduction in test cell; detecting an increase or decrease in methylation; marker for progression to invasive cervical cancer and metastatic potential of cervical lesions |
| 03/10/2009 | US7501259 hydrolase enzyme immobilized within polyelectrolyte (polyethyleneimine, polyacrylic acid , polystyrene sulfonate, polydiallyldimethylammonium chloride), depositing endcapping agent ( 1,2-dihydroxypropyl methacrylate, 1,2-dihydroxypropyl 4-vinylbenzyl ether), polymerizing end capper; chemical resistance |
| 03/10/2009 | US7501249 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 03/10/2009 | US7501244 Determining prognosis of colon or breast cancer by measuring TTK expression |
| 03/10/2009 | US7501243 Identification of cancerous cells and identifying antitumor drugs by detection of expression levels of tyrosine threonine kinase; inhibiting tumor growth (especially breast and colon cancer)by inhibiting activity of TTK |
| 03/10/2009 | US7501242 Detection of colon or breast cancer by measuring TTK polynucleotide expression |
| 03/10/2009 | US7501134 Biodegradable, formed without the use of surfactant; diagnosis, therapy vaccines, and/or in raising immune response; poly(D,L-lactide-co-glycolide) and antigens such as HIV antigens, meningitis B antigens, streptococcus antigens, hepatitis B virus antigens, hepatitis C virus antigens, pertussis antigens |
| 03/10/2009 | US7501132 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 03/10/2009 | US7501130 Methods for treating myofascial pain |
| 03/10/2009 | US7501125 Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent |
| 03/10/2009 | US7501124 Administering allogenic or xenogeneric cell; complexing with antigen |
| 03/10/2009 | US7501118 Human gene relating to respiratory diseases and obesity |
| 03/10/2009 | US7501117 Proteolytic blood coagulation factor for treatment and prevention of preclampsia and thrombotic disorders |
| 03/10/2009 | US7501116 Placental alkaline phosphatase to control diabetes |
| 03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 03/10/2009 | US7501114 Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases |
| 03/10/2009 | CA2501584C The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 03/10/2009 | CA2252896C Inactivation resistant factor viii |
| 03/10/2009 | CA2197677C A method of selectively destroying neoplastic cells |
| 03/10/2009 | CA2145278C Target binding polypeptide |
| 03/05/2009 | WO2009029885A1 Treatment of autoimmune disease |
| 03/05/2009 | WO2009029847A1 Compositions and methods of using proislet peptides and analogs thereof |
| 03/05/2009 | WO2009029801A2 Selective cytopheresis devices and related methods thereof |
| 03/05/2009 | WO2009029784A1 Inhibition of complement and cellular activation |
| 03/05/2009 | WO2009029678A1 PROTEIN KINASE C-δ INHIBITORS THAT PROTECT AGAINST CELLULAR INJURY AND INFLAMMATION AND PROMOTE ASTROCYTE PROLIFERATION |
| 03/05/2009 | WO2009029342A2 B7-dc variants |
| 03/05/2009 | WO2009029308A1 Medication combinations for the treatment of alcoholism and drug addiction |
| 03/05/2009 | WO2009029235A2 Peptides and proteins for early liver development and anitibodies thereto, and their use in therapeutic diagnosis and treatment |
| 03/05/2009 | WO2009029173A1 Modulation of synaptogenesis |
| 03/05/2009 | WO2009028968A1 Cell marker of melanocyte cell lineage and uses thereof |
| 03/05/2009 | WO2009028917A1 Formulation for inhalation comprising fibroblast growth factor-2 as an effective ingredient for treatment or prevention of asthma and/or chronic obstructive pulmonary disease |
| 03/05/2009 | WO2009028580A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | WO2009028573A1 Use of ribavirin in blood coagulation disorder |
| 03/05/2009 | WO2009028411A1 Immunosuppression weaning agent comprising tumor cell and antitumor agent using the same |
| 03/05/2009 | WO2009028248A1 Cyclic heptapeptide and use of the same |
| 03/05/2009 | WO2009028150A1 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent |
| 03/05/2009 | WO2009027823A2 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. |
| 03/05/2009 | WO2009027814A1 Compositions suitable for treatment of spinal disease, disorder or condition |
| 03/05/2009 | WO2009027752A2 Process for producing hepcidin |
| 03/05/2009 | WO2009027690A1 Diagnostic agent |
| 03/05/2009 | WO2009027561A2 Oral pharmaceutical desmopressin composition |
| 03/05/2009 | WO2009027478A2 A method of removing preservatives from a liquid pharmaceutical preparation |
| 03/05/2009 | WO2009027350A1 Use of sco-spondin peptides for inhibiting or preventing neuronal apoptosis mediated by cell death receptor ligands |
| 03/05/2009 | WO2009027332A1 A modulator of nrg1 for treatment of respiratory disorders |
| 03/05/2009 | WO2009027284A1 Purification of osteopontin |
| 03/05/2009 | WO2009027107A1 Inositol pyrophosphates determine exocytotic capacity |
| 03/05/2009 | WO2009027087A1 Means and methods for treating peripheral and cardiovascular diseases via modulation of arteriogenesis |
| 03/05/2009 | WO2009027076A1 Liquid formulation of g-csf |
| 03/05/2009 | WO2009027063A2 MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES |